UBS Maintains Buy on Constellium, Lowers Price Target to $35
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Alex Stansbury maintains Constellium (NYSE:CSTM) with a Buy and lowers the price target from $38 to $35.
UBS analyst Alex Stansbury maintains Constellium (NYSE:CSTM) with a Buy and lowers the price target from $38 to $35.